Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

XenTech

XenTech?uq=w9if130k
2006 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Grant LATEST DEAL TYPE
3 INVESTORS
Description

Developer of patient-derived tumor xenograft models designed to foster therapeutic development in oncology. The company's models focuses on pre-clinical evaluation of oncology therapeutics by offering translational platforms, developing clinically relevant tumor models and addressing tomorrow's needs in preclinical oncology research.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4, rue Pierre Fontaine
  • 91000 Évry
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore XenTech’s full profile, request a free trial.

XenTech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 16-Mar-2009 00000 Completed Generating Revenue
2. Seed Round 31-Oct-2008 00000 00000 Completed Clinical Trials - General
1. Accelerator/Incubator 01-Jan-2006 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

XenTech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
OSEO Innovation Venture Capital Minority 000 0000 000000 0
Aurinvest Venture Capital Minority 000 0000 000000 0
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0

XenTech Executive Team (10)

Name Title Board
Seat
Contact
Info
Jean-Gabriel Judde Ph.D Co-Founder, President & Chief Scientific Officer
Marie Caussou Chief Financial Officer & Manager, Human Resources
Pascal Leuraud Ph.D Chief Operating Officer & Co-Founder
Delphine Nicolle Ph.D Study Director
Marie Tavernier Study Director

2 Former Executives

You’re viewing 5 of 10 executives. Get the full list »